What's new

Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised

Feb 12, 2025 - 09:18
 0
Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

GSK plans to move vaccine R&D center from Rockville, Md. to the Boston area

Next Article

High-Efficiency Moisture Energy Harvesting at -30 oC via Hybrid Solute Engineering

Related Posts

Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

SPOR and xEVMPD Stakeholder Engagement Webinars : Referentials Management Service (RMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 October 2024, 10:00 (CEST) to 7 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Refer...

Apr 1, 2025  0

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0